PriceTargets.com logo

Cosmos Health - COSM Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.66 As of 04/15/2024 01:00 AM ET
▼ -0.05 (-7.04%)

This chart shows the closing price for COSM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cosmos Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COSM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COSM

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for Cosmos Health in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.66.

This chart shows the closing price for COSM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 polled investment analysts is to buy stock in Cosmos Health. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/23/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/21/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/20/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/18/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/16/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/16/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/15/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/20/2024Taglich BrothersReiterated RatingSpeculative BuyLow
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
Mentions as of
9/18/2023
  • 7 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/18/2023
  • 2 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/17/2023
  • 6 very positive mentions
  • 22 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/17/2023
  • 3 very positive mentions
  • 20 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
1/16/2024
  • 2 very positive mentions
  • 29 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/15/2024
  • 8 very positive mentions
  • 38 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
3/16/2024
  • 7 very positive mentions
  • 40 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
4/15/2024

Current Sentiment

  • 7 very positive mentions
  • 40 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Cosmos Health logo
Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $0.66
Low: $0.63
High: $0.70

50 Day Range

MA: $0.75
Low: $0.62
High: $0.95

52 Week Range

Now: $0.66
Low: $0.61
High: $4.05

Volume

153,380 shs

Average Volume

247,688 shs

Market Capitalization

$11.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

5.97

Frequently Asked Questions

What sell-side analysts currently cover shares of Cosmos Health?

The following sell-side analysts have issued stock ratings on Cosmos Health in the last year: Taglich Brothers.
View the latest analyst ratings for COSM.

What is the current price target for Cosmos Health?

0 Wall Street analysts have set twelve-month price targets for Cosmos Health in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Cosmos Health in the next year.
View the latest price targets for COSM.

What is the current consensus analyst rating for Cosmos Health?

Cosmos Health currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe COSM will outperform the market and that investors should add to their positions of Cosmos Health.
View the latest ratings for COSM.

What other companies compete with Cosmos Health?

Other companies that are similar to Cosmos Health include Biofrontera, Moleculin Biotech, Eterna Therapeutics, AgeX Therapeutics and TFF Pharmaceuticals. Learn More about companies similar to Cosmos Health.

How do I contact Cosmos Health's investor relations team?

Cosmos Health's physical mailing address is 141 W Jackson Blvd Ste 4236, Chicago, Illinois 60604-3220. The company's listed phone number is (312) 536-3102 and its investor relations email address is [email protected]. The official website for Cosmos Health is www.cosmosholdingsinc.com. Learn More about contacing Cosmos Health investor relations.